Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease
Abstract Background The Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) is a 10-item patient-reported outcome (PRO) measure designed to assess the severity of mitochondrial disease symptoms. Analyses of data from a clinical trial with PMM patients were conducted to evaluate the psychometri...
Main Authors: | Chad Gwaltney, Jonathan Stokes, Anthony Aiudi, Iyar Mazar, Sarah Ollis, Emily Love, Amel Karaa, Carrie R. Houts, R. J. Wirth, Alan L. Shields |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-12-01
|
Series: | Journal of Patient-Reported Outcomes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41687-022-00534-y |
Similar Items
-
Mitochondrial myopathies: current diagnosis (I)
by: Tudor Rasanu, et al.
Published: (2010-12-01) -
Diagnostic Testing in Suspected Primary Mitochondrial Myopathy
by: Jose C. Hinojosa, et al.
Published: (2023-02-01) -
The Mitochondrial Epigenome: An Unexplored Avenue to Explain Unexplained Myopathies?
by: Archibold Mposhi, et al.
Published: (2022-02-01) -
Case report: perioperative management of caesarean section for a parturient with mitochondrial myopathy
by: Qiang Zheng, et al.
Published: (2017-07-01) -
Anesthetic care for a child with undiagnosed myopathic/mitochondrial disease for gastrostomy tube placement and muscle biopsy.
by: D. M. Munlemvo, et al.
Published: (2020-01-01)